Phenotypic high-throughput screening identifies aryl hydrocarbon receptor agonism as common inhibitor of toxin-induced retinal pigment epithelium cell death

PLoS One. 2024 Apr 18;19(4):e0301239. doi: 10.1371/journal.pone.0301239. eCollection 2024.

Abstract

The retinal pigment epithelium (RPE) is essential to maintain retinal function, and RPE cell death represents a key pathogenic stage in the progression of several blinding ocular diseases, including age-related macular degeneration (AMD). To identify pathways and compounds able to prevent RPE cell death, we developed a phenotypic screening pipeline utilizing a compound library and high-throughput screening compatible assays on the human RPE cell line, ARPE-19, in response to different disease relevant cytotoxic stimuli. We show that the metabolic by-product of the visual cycle all-trans-retinal (atRAL) induces RPE apoptosis, while the lipid peroxidation by-product 4-hydroxynonenal (4-HNE) promotes necrotic cell death. Using these distinct stimuli for screening, we identified agonists of the aryl hydrocarbon receptor (AhR) as a consensus target able to prevent both atRAL mediated apoptosis and 4-HNE-induced necrotic cell death. This works serves as a framework for future studies dedicated to screening for inhibitors of cell death, as well as support for the discussion of AhR agonism in RPE pathology.

MeSH terms

  • Apoptosis
  • Cell Death
  • High-Throughput Screening Assays*
  • Humans
  • Oxidative Stress
  • Receptors, Aryl Hydrocarbon / metabolism
  • Retinal Pigment Epithelium* / metabolism

Substances

  • Receptors, Aryl Hydrocarbon

Grants and funding

All authors are either current or former employees of Ophthalmology, Biomedical Research, Novartis. The study, data collection, analysis, decision to publish and preparation of the manuscript was done and funded by Novartis Pharma AG, Basel, Switzerland.